Metagenomi to Participate in Upcoming Investor Conferences

EMERYVILLE, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today announced that it will present during the following upcoming investor conferences: Wells Fargo Healthcare Conference, Everett, Massachusetts Fireside chat on Wednesday, September 4, 2024, 11:00 AM - 11:35 AM ET with Brian Thomas, CEO, Dr. Sarah Noonberg, CMO, and Alan Brooks, SV ...